amdocs - DOX

DOX

Close Chg Chg %
82.94 0.79 0.95%

Pre-Market

83.73

+0.79 (0.95%)

Volume: 565.81K

Last Updated:

Nov 20, 2024, 4:00 PM EDT

Company Overview: amdocs - DOX

DOX Key Data

Open

$82.84

Day Range

82.84 - 83.78

52 Week Range

74.41 - 94.04

Market Cap

$9.47B

Shares Outstanding

114.19M

Public Float

113.52M

Beta

0.75

Rev. Per Employee

N/A

P/E Ratio

19.52

EPS

$4.26

Yield

225.71%

Dividend

$0.48

EX-DIVIDEND DATE

Dec 31, 2024

SHORT INTEREST

N/A

AVERAGE VOLUME

679.27K

 

DOX Performance

1 Week
 
-0.30%
 
1 Month
 
-5.78%
 
3 Months
 
-1.99%
 
1 Year
 
0.76%
 
5 Years
 
22.32%
 

DOX Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 10
Full Ratings ➔

About amdocs - DOX

Amdocs Ltd. operates as a holding company, which engages in the provision of software products and services for communications, entertainment, and media industry service providers. The company was founded in 1988 and is headquartered in Saint Louis, MO.

DOX At a Glance

Amdocs Ltd.
625 Maryville Centre Drive
St. Louis, Missouri 63141
Phone 1-314-212-7000 Revenue 5.00B
Industry Information Technology Services Net Income 496.32M
Sector Technology Services 2024 Sales Growth 2.427%
Fiscal Year-end 09 / 2025 Employees N/A
View SEC Filings

DOX Valuation

P/E Current 19.515
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 20.584
Price to Sales Ratio 2.03
Price to Book Ratio N/A
Price to Cash Flow Ratio 14.025
Enterprise Value to EBITDA 11.032
Enterprise Value to Sales 2.094
Total Debt to Enterprise Value 0.075

DOX Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 4.867
Total Asset Turnover 0.781

DOX Liquidity

Current Ratio 1.204
Quick Ratio N/A
Cash Ratio 0.35

DOX Profitability

Gross Margin 33.773
Operating Margin 15.119
Pretax Margin 11.81
Net Margin 9.917
Return on Assets 7.748
Return on Equity 14.22
Return on Total Capital 11.687
Return on Invested Capital 11.681

DOX Capital Structure

Total Debt to Total Equity 22.845
Total Debt to Total Capital 18.596
Total Debt to Total Assets 12.366
Long-Term Debt to Equity 21.688
Long-Term Debt to Total Capital 17.655
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Amdocs - DOX

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
4.29B 4.58B 4.89B 5.00B
Sales Growth
+2.90% +6.69% +6.78% +2.43%
Cost of Goods Sold (COGS) incl D&A
2.91B 3.01B 3.18B 3.31B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
208.83M 224.53M 195.70M 193.07M
Depreciation
125.01M 127.45M 128.02M 131.01M
Amortization of Intangibles
83.82M 97.09M 67.68M 62.05M
COGS Growth
+2.74% +3.29% +5.79% +4.07%
Gross Income
1.37B 1.57B 1.70B 1.69B
Gross Income Growth
+3.25% +13.91% +8.69% -0.66%
Gross Profit Margin
+32.04% +34.21% +34.82% +33.77%
2021 2022 2023 2024 5-year trend
SG&A Expense
815.10M 871.42M 925.24M 933.64M
Research & Development
320.20M 349.13M 364.63M 360.80M
Other SG&A
494.90M 522.29M 560.61M 572.85M
SGA Growth
+9.58% +6.91% +6.18% +0.91%
Other Operating Expense
- - - -
-
Unusual Expense
(9.08M) 15.43M 91.41M 128.09M
EBIT after Unusual Expense
568.35M 678.70M 684.87M 628.61M
Non Operating Income/Expense
- 267.23M (13.38M) (25.42M)
Non-Operating Interest Income
- 4.82M 7.82M 21.25M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
21.27M 16.91M 23.09M 37.54M
Interest Expense Growth
+104.04% -20.51% +36.56% +62.55%
Gross Interest Expense
21.27M 16.91M 23.09M 37.54M
Interest Capitalized
- - - -
-
Pretax Income
814.31M 648.41M 636.36M 591.07M
Pretax Income Growth
+39.60% -20.37% -1.86% -7.12%
Pretax Margin
+18.99% +14.17% +13.02% +11.81%
Income Tax
125.93M 98.91M 93.40M 94.75M
Income Tax - Current - Domestic
- 176.54M 102.20M 153.61M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- (50.60M) (3.29M) (60.21M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- (7.05M) (7.88M) (9.17M)
Consolidated Net Income
681.32M 541.62M 533.79M 499.44M
Minority Interest Expense
- - 2.25M 3.12M
-
Net Income
681.32M 541.62M 531.54M 496.32M
Net Income Growth
+37.87% -20.50% -1.86% -6.63%
Net Margin Growth
+15.88% +11.84% +10.88% +9.92%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
681.32M 541.62M 531.54M 496.32M
Preferred Dividends
- - - -
-
Net Income Available to Common
681.32M 541.62M 531.54M 493.20M
EPS (Basic)
5.3572 4.4743 4.5177 4.2705
EPS (Basic) Growth
+43.76% -16.48% +0.97% -5.47%
Basic Shares Outstanding
127.18M 121.05M 117.66M 115.49M
EPS (Diluted)
5.3244 4.4438 4.4863 4.25
EPS (Diluted) Growth
+43.56% -16.54% +0.96% -5.27%
Diluted Shares Outstanding
127.97M 121.89M 118.49M 116.14M
EBITDA
768.10M 918.67M 971.99M 949.76M
EBITDA Growth
-2.23% +19.60% +5.80% -2.29%
EBITDA Margin
+17.91% +20.07% +19.89% +18.98%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 100.143
Number of Ratings 10 Current Quarters Estimate 1.637
FY Report Date 12 / 2024 Current Year's Estimate 6.972
Last Quarter’s Earnings 1.70 Median PE on CY Estimate N/A
Year Ago Earnings 6.44 Next Fiscal Year Estimate 7.553
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 7 7 7 7
Mean Estimate 1.64 1.71 6.97 7.55
High Estimates 1.67 1.77 7.03 7.67
Low Estimate 1.60 1.66 6.92 7.39
Coefficient of Variance 1.26 2.33 0.54 1.29

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 6 6 5
OVERWEIGHT 2 2 2
HOLD 2 2 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Amdocs in the News